This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Silicone hydrogel contact lenses versus autologous serum drops for dry eyes in Sjörgen syndrome

Silicone hydrogel contact lenses versus autologous serum drops for dry eyes in Sjörgen syndrome
Reviewed by Magdalena Popiela

1 October 2015 | Magdalena Popiela | EYE - Cornea, EYE - General

A total of 37 patients with Sjörgen syndrome (SS) related dry eyes reporting symptoms on standard therapy with artificial tears and anti-inflammatory drops were evaluated in this trial. They were randomly assigned to additional treatment with either balafilcon A silicone hydrogel contact lenses (BCL) or 50% autologous serum drops (AS). Patients were assessed objectively (visual acuity, Schirmer 1 test, tear break up time (tBUT), conjunctival staining) and subjectively (Ocular Surface Disease Index (OSDI) and faces scale) at three and six weeks of therapy plus six weeks after intervention discontinuation. All of the 18 patients in AS and 19 patients in BCL groups had significant improvements in ocular comfort, conjunctival staining and tBUT from pre-treatment levels. No significant effect of either treatment on Schirmer test was noted. The BCL group had significantly lower OSDI, faces and conjunctival staining scores compared to AS group at all study time points. Visual acuity improved significantly only in the BCL group from pre-treatment levels but was not statistically different between studied groups at all study time points. No adverse effects of either therapy were reported. Although a small study with a short follow-up, where the authors did not specify if examiners were blinded to the interventions, it suggests both BCL and AS can be effective treatment adjuncts for patients with SS related dry eyes. The BCL are well-tolerated showing better and more longstanding outcomes compared to the AS drops.

Comparative evaluation of silicone hydrogel contact lenses and autologous serum for management of sjögren syndrome-associated dry eye.
Li J, Zhang X, Zheng Q, Zhu Y, et al.
CORNEA
2015;34(9):1072-8.
Share This
Magdalena Popiela
CONTRIBUTOR
Magdalena Popiela

Royal Gwent Hospital, Cardiff, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency